HUP0401514A2 - Asztma kezelésére alkalmas gyógyszerkészítmények és eljárás az előállításukra - Google Patents

Asztma kezelésére alkalmas gyógyszerkészítmények és eljárás az előállításukra

Info

Publication number
HUP0401514A2
HUP0401514A2 HU0401514A HUP0401514A HUP0401514A2 HU P0401514 A2 HUP0401514 A2 HU P0401514A2 HU 0401514 A HU0401514 A HU 0401514A HU P0401514 A HUP0401514 A HU P0401514A HU P0401514 A2 HUP0401514 A2 HU P0401514A2
Authority
HU
Hungary
Prior art keywords
asthma
treatment
pharmaceutical compositions
mometasone furoate
formoterol fumarate
Prior art date
Application number
HU0401514A
Other languages
English (en)
Inventor
Joel A. Sequeira
Stefan A. Sharpe
John L. Hart
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23224164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0401514(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of HUP0401514A2 publication Critical patent/HUP0401514A2/hu
Publication of HUP0401514A3 publication Critical patent/HUP0401514A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A tálálmány mometazon-furoátot és formoterol-fumarátot tartalmazó,asztma kezelésére alkalmas aeroszol készítményekre és ilyenkészítmények előállítására alkalmas eljárásokra vonatkozik. Ahordozóanyagtól lényegében mentes készítményben a mometazon-furoát ésa formoterol-fumarát aránya körülbelül 400 <g mometazon-furoát :körülbelül 12 <g formoterol-fumarát és körülbelül 50 <g mometazon-furoát : körülbelül 6 <g formoterol-fumarát közötti. Ó
HU0401514A 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma HUP0401514A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31538601P 2001-08-28 2001-08-28
PCT/US2002/027336 WO2003020253A2 (en) 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma

Publications (2)

Publication Number Publication Date
HUP0401514A2 true HUP0401514A2 (hu) 2004-12-28
HUP0401514A3 HUP0401514A3 (en) 2012-08-28

Family

ID=23224164

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401514A HUP0401514A3 (en) 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma

Country Status (27)

Country Link
US (3) US20030114428A1 (hu)
EP (3) EP1420759B1 (hu)
JP (3) JP2005502675A (hu)
KR (1) KR100970531B1 (hu)
CN (2) CN101856362A (hu)
AR (1) AR036358A1 (hu)
AT (2) ATE503461T1 (hu)
AU (1) AU2002313828B2 (hu)
BR (1) BR0212089A (hu)
CA (1) CA2457926A1 (hu)
CO (1) CO5560551A2 (hu)
CY (2) CY1109212T1 (hu)
DE (2) DE60232251D1 (hu)
DK (2) DK1420759T3 (hu)
ES (3) ES2361805T3 (hu)
HK (3) HK1060972A1 (hu)
HU (1) HUP0401514A3 (hu)
MX (1) MXPA04001875A (hu)
NO (1) NO20041277L (hu)
NZ (1) NZ530987A (hu)
PE (1) PE20030390A1 (hu)
PL (1) PL209640B1 (hu)
PT (2) PT1420759E (hu)
SI (2) SI2092935T1 (hu)
TW (1) TWI324934B (hu)
WO (1) WO2003020253A2 (hu)
ZA (1) ZA200401419B (hu)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
CZ301676B6 (cs) * 2001-03-30 2010-05-19 Jagotec Ag Farmaceutický suspenzní aerosolový prípravek pro inhalaci a použití soli karboxylové kyseliny
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
EP1785156B1 (en) * 2002-08-23 2012-06-27 Schering Corporation Metered dose inhaler containing an aerosol suspension formulation
CA2495689A1 (en) * 2002-08-23 2004-03-04 Schering Corporation Pharmaceutical compositions
EP1878664B1 (en) * 2002-08-27 2011-03-30 Schering Corporation Process for producing metered dose inhaler formulations
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323684D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
BRPI0415707A (pt) * 2003-10-20 2006-12-19 Schering Corp composições farmacêuticas
DK1711164T3 (da) * 2004-01-21 2010-07-19 Schering Corp Fremgangsmåde til behandling af akut rhinosinusitis
US20110053999A1 (en) 2004-03-03 2011-03-03 Daley Thomas E 4-methylpyrazole formulations for inhibiting ethanol intolerance
ES2317306T3 (es) * 2004-10-12 2009-04-16 Generics (Uk) Limited Procedimiento para la preparacion de formulaciones en aerosol en suspension, en el que las particulas se forman por precipitacion dentro de un frasco de aerosol.
US20090298802A1 (en) 2005-03-30 2009-12-03 Sequeira Joel A Pharmaceutical Compositions
AR059357A1 (es) * 2006-02-09 2008-03-26 Schering Corp Formulaciones farmaceuticas
AU2007346134A1 (en) * 2007-02-09 2008-08-14 Merck Sharp & Dohme Corp. Stable pharmaceutical drug aerosols
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
GB0714239D0 (en) * 2007-07-20 2007-08-29 Glaxo Group Ltd Method
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20110182830A1 (en) * 2008-01-10 2011-07-28 Schering Corporation Inhalation drug products, systems and uses
GB0801876D0 (en) 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
EP2435024B1 (en) * 2009-05-29 2016-07-06 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2011027247A1 (en) 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
CA2781792C (en) 2009-11-25 2019-04-02 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
TWI490209B (zh) * 2009-12-07 2015-07-01 雷普特治療有限責任公司 ４－甲基吡唑調配物
WO2011101830A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it
WO2011101828A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sidium fusidate and incorporating a biopolymer and betamethasone, and a process to make it
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012017368A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it
WO2012049543A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
CA2850084C (en) 2011-10-11 2020-07-07 Chiesi Farmaceutici S.P.A. Crystalline microparticles of a beta-agonist coated with a fatty acid
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
KR102391332B1 (ko) 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
US10195374B2 (en) 2014-05-07 2019-02-05 Boehringer Ingelheim International Gmbh Container, nebulizer and use
ES2913297T3 (es) 2014-05-07 2022-06-01 Boehringer Ingelheim Int Nebulizador
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
US9360400B2 (en) 2014-06-30 2016-06-07 Proveris Scientific Corporation Sampling apparatus for determining the amount and uniformity of a delivered dose of drug and related methods
ES2866175T3 (es) 2015-12-04 2021-10-19 Mexichem Fluor Sa De Cv Composición farmacéutica
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
CA3016890A1 (en) * 2016-03-09 2017-09-14 Proveris Scientific Corporation Methods for measuring dose content uniformity performance of inhaler and nasal devices
CN106619658B (zh) * 2016-12-28 2022-02-08 四川普锐特药业有限公司 一种医用气溶胶制剂及定量吸入气雾剂
WO2021219495A1 (en) 2020-04-28 2021-11-04 Dalcor Pharma Uk Ltd., Leatherhead, Zug Branch Methods for treating or preventing a viral infection or inhibiting viral replication

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
ES2200771T3 (es) * 1991-06-10 2004-03-16 Schering Corporation Formulaciones en aerosol no clorofluorocarbonadas.
US6250300B1 (en) * 1992-12-11 2001-06-26 Ab Astra System for dispensing pharmaceutically active compounds
EE9700138A (et) * 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
ES2159148T3 (es) * 1996-08-29 2001-09-16 Schering Corp Formulaciones en aerosol de furoato de mometasona libres de clorofluorocarbonos.
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6495167B2 (en) * 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
TW533865U (en) * 1997-06-10 2003-05-21 Glaxo Group Ltd Dispenser for dispensing medicament and actuation indicating device
WO2000030654A1 (en) * 1998-11-26 2000-06-02 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
AU3728001A (en) * 2000-01-20 2001-07-31 Basilea Pharmaceutica Ag Nasally administrable cyclic peptide compositions
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
TW200301698A (en) * 2001-12-21 2003-07-16 Bristol Myers Squibb Co Acridone inhibitors of IMPDH enzyme

Also Published As

Publication number Publication date
PT2092935E (pt) 2011-05-31
HUP0401514A3 (en) 2012-08-28
JP2005502675A (ja) 2005-01-27
CN1649568B (zh) 2010-10-27
DK1420759T3 (da) 2009-08-03
JP5170789B2 (ja) 2013-03-27
EP1420759B1 (en) 2009-05-06
ATE503461T1 (de) 2011-04-15
NZ530987A (en) 2006-08-31
CY1109212T1 (el) 2014-07-02
ZA200401419B (en) 2005-01-26
PL209640B1 (pl) 2011-09-30
PE20030390A1 (es) 2003-04-24
US20100143269A1 (en) 2010-06-10
AU2002313828B2 (en) 2005-09-08
PL368897A1 (en) 2005-04-04
HK1128428A1 (en) 2009-10-30
TWI324934B (en) 2010-05-21
KR100970531B1 (ko) 2010-07-16
EP2319494B1 (en) 2012-06-13
JP2009185075A (ja) 2009-08-20
DK2092935T3 (da) 2011-07-18
AR036358A1 (es) 2004-09-01
EP2092935A1 (en) 2009-08-26
EP2319494A1 (en) 2011-05-11
ES2361805T3 (es) 2011-06-22
NO20041277L (no) 2004-03-26
CO5560551A2 (es) 2005-09-30
WO2003020253A2 (en) 2003-03-13
JP2010138184A (ja) 2010-06-24
CY1111726T1 (el) 2015-10-07
KR20040031002A (ko) 2004-04-09
ES2389480T3 (es) 2012-10-26
DE60239648D1 (de) 2011-05-12
US20030114428A1 (en) 2003-06-19
EP1420759A2 (en) 2004-05-26
US20050147565A1 (en) 2005-07-07
EP2092935B1 (en) 2011-03-30
CN1649568A (zh) 2005-08-03
CA2457926A1 (en) 2003-03-13
SI2092935T1 (sl) 2011-07-29
ES2325316T3 (es) 2009-09-01
WO2003020253A3 (en) 2003-05-22
PT1420759E (pt) 2009-06-30
BR0212089A (pt) 2004-08-03
SI1420759T1 (sl) 2009-10-31
HK1060972A1 (en) 2004-09-03
HK1151987A1 (en) 2012-02-17
MXPA04001875A (es) 2004-06-15
ATE430555T1 (de) 2009-05-15
DE60232251D1 (de) 2009-06-18
CN101856362A (zh) 2010-10-13

Similar Documents

Publication Publication Date Title
HUP0401514A2 (hu) Asztma kezelésére alkalmas gyógyszerkészítmények és eljárás az előállításukra
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
MY129422A (en) Medicinal compounds
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
HUP0301447A2 (hu) Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények
ATE203901T1 (de) Fluorchlorkohlenwasserstofffreie aerosolformulierungen
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
WO2003032928A3 (en) Therapeutic composition and use
HUP0002691A2 (hu) Ciklezonid tartalmú gyógyászati aeroszol termékek
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
CA2400217A1 (en) Pteridine compounds for the treatment of psoriasis
HUP0301349A2 (hu) IL-11-tartalmú készítmények
HUP0400600A2 (hu) Inhaláló készülék kimért adagnyi szalmeterol-xinafoáthoz
HUP0201834A3 (en) Use of thyromimetic compounds for the manufacture of a pharmaceutical composition for the treatment of hair loss and such compositions
WO2001076601A3 (en) Pharmaceutical compositions comprising salmeterol and ipratropium
HUP0002533A2 (hu) Asztmaellenes gyógyszerhatóanyagok új kombinációja
WO2003035043A3 (en) Pharmaceutical formulation comprising more than 15% tamoxifen
HUP0204528A2 (en) Use of de deramciclane for preparation of pharmaceutical composition available for treatment of disorders relating to serotonergic system
HUP0000812A2 (hu) Myelin bázikus fehérje peptid-fragmentumai az azokat tartalmazó gyógyszerkészítmények és felhasználásuk a sclerosis multiplex kezelésére
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS
WO2002072527A3 (de) 1-butansäurederivate wie z.b. carbomethoxypropionylcyanid oder leflunomidderivate und deren therapeutische anwendung
AU2002325687A1 (en) Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: MERCK SHARP & DOHME CORP., US

Free format text: FORMER OWNER(S): SCHERING CORPORATION, US

FD9A Lapse of provisional protection due to non-payment of fees